Use of Shockwave therapy versus placebo in the treatment of tight calf muscles in children with cerebral palsy

Prospective double blind RCT comparing radial Extracorporeal Shockwave therapy (rESWT) vs placebo in treatment of calf spasticity in children with cerebral palsy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019666

Enrollment

Registered

2019-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G801- Spastic diplegic cerebral palsy Health Condition 2: G802- Spastic hemiplegic cerebral palsy Health Condition 3: G800- Spastic quadriplegic cerebral palsy

Interventions

Intervention1: radial extracorporeal shock wave therapy: rESWT 1500 shots, 5 Hz, 0.03mJ/mm3 2 sittings , on day 1 and day 4 Control Intervention1: sham ESWT: sham ESWT

Eligibility

Inclusion criteria

Inclusion criteria: Children with CP under 7 years of age with calf spasticity, MAS of 2 or more

Exclusion criteria

Exclusion criteria: Previous surgery to calf Botox injection to the calf Inability to comply with followup Bleeding disorders/blood dyscrasias/ seizure disorder

Design outcomes

Primary

Measure	Time frame
Calibrated passive range of motion of the ankleTimepoint: Immediate procedure 6 weeks 3 months	—

Secondary

Measure	Time frame
Modified Ashworth Scale (MAS) Parent reported satisfaction on likert scale Serious adverse effectsTimepoint: 6 weeks and 3 months	—

Countries

India

Contacts

Public ContactAbhay Gahukamble

Christian Medical College,Vellore

abhayg@cmcvellore.ac.in9600272174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026